Irbaz Bin Riaz
- Transplantation top 2%
- Health Informatics top 2%
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 13
- Hepatology top 5%
- Oncology top 5%
- Cancer Treatment and Pharmacology 20
-
- Prostate Cancer Treatment and Research 37
-
- Radiopharmaceutical Chemistry and Applications 19
- Radiomics and Machine Learning in Medical Imaging 19
-
- Bladder and Urothelial Cancer Treatments 16
-
- Multiple Myeloma Research and Treatments 15
-
- Cancer Genomics and Diagnostics 14
- Co-authors
- M. Hassan MuradJawad BilalFaiz AnwerHaris RiazAbbas RanaRainer W.G. GruessnerAngelika C. GruessnerMuhammad Shahzeb Khan
- Partner nations
- United StatesPakistanUnited Kingdom
In The Last Decade
Irbaz Bin Riaz
185 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Transplantation 197
- Health Informatics 61
- Internal Medicine 151
- Hepatology 250
- Oncology 785
Countries citing papers authored by Irbaz Bin Riaz
This map shows the geographic impact of Irbaz Bin Riaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irbaz Bin Riaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irbaz Bin Riaz more than expected).
Fields of papers citing papers by Irbaz Bin Riaz
This network shows the impact of papers produced by Irbaz Bin Riaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irbaz Bin Riaz. The network helps show where Irbaz Bin Riaz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Irbaz Bin Riaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 9 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 21 | |
| 12 | 2023 | 1 | |
| 13 | Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial | 2022 | 20 |
| 14 | 2022 | 24 | |
| 15 | 2022 | 65 | |
| 16 | 2022 | 10 | |
| 17 | 2020 | 31 | |
| 18 | 2018 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2016 | 1 |
About Irbaz Bin Riaz
Irbaz Bin Riaz is a scholar working on Health Informatics, Internal Medicine and Oncology, having authored 213 papers that have together received 3.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (37 papers), Cancer Treatment and Pharmacology (20 papers), Radiopharmaceutical Chemistry and Applications (19 papers), Radiomics and Machine Learning in Medical Imaging (19 papers), Bladder and Urothelial Cancer Treatments (16 papers), Multiple Myeloma Research and Treatments (15 papers), Cancer Genomics and Diagnostics (14 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). The work is most often cited by research in Transplantation (197 citations), Health Informatics (61 citations) and Internal Medicine (151 citations). Irbaz Bin Riaz has collaborated with scholars based in United States, Pakistan and United Kingdom. Frequent co-authors include M. Hassan Murad, Jawad Bilal, Faiz Anwer, Haris Riaz, Abbas Rana, Rainer W.G. Gruessner, Angelika C. Gruessner, Muhammad Shahzeb Khan, Bruce Kaplan and Muhammad Husnain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.